See also this year's filing and all EDGAR filings for this company.
PDF Report 0001434868_2023_Esperion_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001434868, Esperion Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 246,683,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 56,000 |
| 2 | PropertyPlantAndEquipmentNet | 164,000 |
| 3 | remainder_Assets | 1,036,000 |
| 4 | LiabilitiesCurrent | 92,308,000 |
| 5 | LiabilitiesNoncurrent | 665,000 |
| 6 | remainder_Liabilities | 478,744,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 109,082,000 |
| 9 | ResearchAndDevelopmentExpense | 118,927,000 |
| 10 | remainder_Expenses | 83,777,000 |
| 11 | remainder_Revenues | 75,475,000 |
| 12 | remainder_NetIncome | 2,652,000 |
| 13 | remainder_ComprehensiveNetIncome | 29,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 247,939,000 |
| 1 | Liabilities | 571,717,000 |
| 2 | Expenses | 311,786,000 |
| 3 | Revenues | 75,475,000 |
| 4 | StockholdersEquity | -323,778,000 |
| 5 | NetIncome | -233,659,000 |
| 6 | ComprehensiveNetIncome | -233,644,500 |
| 7 | BaseVar | 604,799,000 |
| 8 | EconomicCapitalRatio | -1.93 |
Edgar->Model Mapping
Feature Distribution
Change over Time
